´ëÇѾÏÇÐȸ Á¦3ȸ Korean Immuno-Oncology Symposium : 2020-02-28±³À°ÀÏÀÚ : 2020-02-28
±³À°Àå¼Ò : ¼¿ï·Ôµ¥È£ÅÚ 2Ãþ Å©¸®½ºÅ»º¼·ë
±³À°ÁÖÁ¦ :
Á¦3ȸ Korean Immuno-Oncology SymposiumÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 02-792-1486
À̸ÞÀÏ :
cancer4@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаúÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 55ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í 1. »çÀüµî·Ï: 1) ¾ÏÇÐȸ/¸é¿ªÇÐȸ ȸ¿ø: 5¸¸¿ø, 2) ºñȸ¿ø: 7¸¸¿ø 3) ¾÷ü/¿¬±¸¼Ò: 8¸¸¿ø 4) Àü°øÀÇ/´ëÇпø»ý: 4¸¸¿ø 2. ÇöÀåµî·Ï: 1) ¾ÏÇÐȸ/¸é¿ªÇÐȸ ȸ¿ø: 7¸¸¿ø, 2) ºñȸ¿ø: 9¸¸¿ø 3) ¾÷ü/¿¬±¸¼Ò: 10¸¸¿ø 4) Àü°øÀÇ/´ëÇпø»ý: 6¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 09:10~09:35 NK cell Renier J. Brentjens(Memorial Sloan Kettering Cancer Center)
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 09:35~10:00 Reneration of cytotoxic T lymphocytes from pluripotent stem cells -Development of ¡°off-the-shelf T cells¡± for cancer immunotherapy- Hiroshi Kawamoto(Kyoto University)
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 10:00~10:25 T-cell immunotherapy through engineering of TCR microclusters Àüâ´ö(±¤ÁÖ°úÇбâ¼ú¿ø)
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 10:25~10:50 Discovery of a novel splenic subset of dendritic cells and harnessing their potential in immunotherapies ¹Úä±Ô(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 02-28 Å©¸®½ºÅ»º¼·ë 10:50~11:10 ÈÞ½Ä ()
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 11:10~11:35 Therapeutic cancer vaccines °ÅÂÈï(°Ç±¹ÀÇ´ë ¸é¿ªÇÐ)
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 11:35~12:00 DC vaccine targeting neoantigens Kazuhiro Kakimi(The University of Tokyo Hospital)
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 12:00~12:25 The potential application of exosome inhibitor to improve immuno-oncology therapy ¹é¹®Ã¢(°æºÏÀÇ´ë ºÐÀÚÀÇÇÐ)
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 12:25~13:25 RCC To be announced()
½Ä»ç 02-28 Å©¸®½ºÅ»º¼·ë 13:25~13:40 ½Ä»ç ()
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 13:40~14:10 Insights for biology-based combinations to tackle advanced urologic cancer ±èÂù(Â÷ÀÇ´ë Á¾¾ç³»°ú)
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 14:10~14:40 Neoadjuvant/Adjuvant immunotherapy in early lung cancer and breast cancer ¾ÈÈñ°æ(°¡ÃµÀÇ´ë Á¾¾ç³»°ú)
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 14:40~15:10 Peripheral blood biomarker related to immune check point inihibitor in non-small cell lung cancer ¾È¸íÁÖ(¼º±Õ°üÀÇ´ë Á¾¾ç³»°ú)
ÈÞ½Ä 02-28 Å©¸®½ºÅ»º¼·ë 15:10~15:30 ÈÞ½Ä ()
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 15:30~16:00 Novel radiotherapy and immunotherapy approaches for oligometastatic cancer ÀåÁö¼®(¿¬¼¼ÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú)
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 16:00~16:30 Exploring signals of synergy in clinical practice ½Å»óÁØ(¿¬¼¼ÀÇ´ë Á¾¾ç³»°ú)
±³À°½Ã°£ 02-28 Å©¸®½ºÅ»º¼·ë 16:30~17:00 SBRT vs. CFRT in inducing the abscopal effect ¹Ú¼¼±¤(ÀÎÁ¦ÀÇ´ë ¹Ì»ý¹°ÇÐ)